Asset Dedication, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1475896
SAN FRANCISCO, CA
Position in ALNY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,806
+$152 QoQ
Shares Held
6
+20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#744
of 786 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Asset Dedication, LLC holds $189,361 across 9 Biotechnology names. ALNY ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
237 | $117,725 | |
| 2 | MRNA |
Moderna, Inc.
|
843 | $59,035 | |
| 3 | BNTX |
BioNTech SE
|
37 | $3,442 | |
| 4 | RPRX |
Royalty Pharma plc
|
49 | $2,747 | |
| 5 | NNVC |
Nanoviricides, Inc.
|
1,450 | $2,001 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
6 | $1,806 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
184 | $1,801 | |
| 8 | NVAX |
Novavax Inc
|
65 | $612 |
All Filings in ALNY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,806 | 6 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,654 | 5 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $1,988 | 5 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,280 | 5 | Shares | Sole | 2025-11-20 | |
| 2022-12-31 | $237 | 1 | Shares | Sole | 2023-01-19 | |
| 2021-09-30 | $3,020 | 16 | Shares | Sole | 2021-10-18 | |
| No filing history on record for this holder in this stock. | ||||||